We are redefining digestive health by pioneering non-endoscopic diagnostics, enabling early detection of diseases and access to care for everyone, everywhere.
Cyted Health has raised €37M across 1 funding round from 5 investors, most recently a Series B round in Sep 2025. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-02 | Series B | €37M |
| Advent Life Sciences,BGF,British Business Bank,EQT Life Sciences,Morningside |
| View deal → |
